Page 21 - டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India-Russia talks comprehensive and productive ; S-400 to be discussed later this year

India-Russia talks “comprehensive and productive’’; S-400 to be discussed later this year Huma Siddiqui © Provided by The Financial Express Post COVID, both India and Russia are in talks of deepening their vaccine cooperation. (Representational Image) Top ministers of India and Russia met in New Delhi on Tuesday (April 6, 2021) and had wide range of discussion with focus on issues related to defence cooperation and weapons manufacturing, Afghanistan, partnership in nuclear, space and economic cooperation. An expected visit of the Russian President Vladimir Putin later this year for the annual summit as well as vaccine cooperation was discussed today. India-Russia Bilateral Relations:

Permskiy krayUnited statesNew delhiNorth koreaAshraf ghaniVladimir putinSergei lavrovDr reddy laboratories ltdRepresentational imageFinancial express postRussian president vladimir putinRussia bilateral relationsAffairs minister drs jaishankarRussian foreign minister sergei lavrovFinancial express onlineCountering america

India s Gland Pharma to make up to 252 million Sputnik V vaccine doses

India s Gland Pharma to make up to 252 million Sputnik V vaccine doses
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshAnuron kumar mitraDevika syamnathThomson reuters trust principlesGland pharma ltdShanghai fosun pharmaceutical group co ltdAstrazeneca plcDr reddy laboratories ltdRussian direct investment fundEuropean unionMoscow gamaleya institutePharma ltdGland pharmaGamaleya instituteLaboratories ltdThomson reuters trust

India s Gland Pharma to make up to 252 million Sputnik V vaccine doses

Sputnik V, developed by Moscow s Gamaleya Institute, has been approved in 22 countries, with the RDIF signing supply deals with over 13 countries.

Andhra pradeshGland pharma ltdShanghai fosun pharmaceutical group co ltdAstrazeneca plcDr reddy laboratories ltdRussian direct investment fundEuropean unionMoscow gamaleya instituteGland pharmaGamaleya instituteLaboratories ltdSputnikv vaccineDr reddys laboratories ltdஆந்திரா பிரதேஷ்சுரப்பி பார்மா லிமிடெட்டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட்

Gland Pharma strikes deal with RDIF

Gland Pharma strikes deal with RDIF
sanantoniopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sanantoniopost.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshGland pharma ltd onDr reddy laboratories ltdRussian direct investment fundBombay stock exchangeGland pharma ltdGland pharmaDrug substanceDrug productLaboratories ltdஆந்திரா பிரதேஷ்சுரப்பி பார்மா லிமிடெட் ஆன்டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட்ரஷ்ய நேரடி முதலீடு நிதிகுண்டு ஸ்டாக் பரிமாற்றம்சுரப்பி பார்மா லிமிடெட்

Gland Pharma inks deal with RDIF for 252mn doses of Sputnik V vaccine

Gland Pharma inks deal with RDIF for 252mn doses of Sputnik V vaccine ANI | Updated: Mar 16, 2021 22:34 IST Mumbai (Maharashtra) [India], March 16 (ANI): Gland Pharma Ltd on Tuesday said that it has entered into an agreement with the Russian Direct Investment Fund (RDIF) for the supply of 252 million doses of Sputnik V (Russian made) vaccine against COVID-19. Gland Pharma will be leveraging its manufacturing capabilities for the production of Sputnik V COVID-19 vaccine. The agreement will see Gland Pharma utilising its Drug Substance and Drug Product facilities at its sites in Hyderabad, the statement published by the Bombay Stock Exchange said, as quoted by Sputnik.

Andhra pradeshGland pharma ltd onDr reddy laboratories ltdRussian direct investment fundBombay stock exchangeGland pharma ltdGland pharmaDrug substanceDrug productLaboratories ltdSputnik vCovid vaccineஆந்திரா பிரதேஷ்சுரப்பி பார்மா லிமிடெட் ஆன்டாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட்ரஷ்ய நேரடி முதலீடு நிதி